Publications 2023:

a. Eliminating cccDNA to cure hepatitis B virus infection. Zoulim F, Testoni B. J Hepatol. 2023 Jan 27:S0168-8278(23)00029-6. doi: 10.1016/j.jhep.2023.01.017. Online ahead of print. PMID: 36717025.

b. The scientific basis of combination therapy for chronic hepatitis B functional cure. Lim SG, Baumert TF, Boni C, Gane E, Levrero M, Lok AS, Maini MK, Terrault NA, Zoulim F. Nat Rev Gastroenterol Hepatol. 2023 Jan 11. doi: 10.1038/s41575-022-00724-5. Online ahead of print. PMID: 36631717 Review.

Before 2023:

c. Refining the DC-targeting vaccination for preventing emerging infectious diseases. Yadira Pastor, Nour Ghazzaui, Adele Hammoudi, Mireille Centlivre, Sylvain Cardinaud1 and Yves Levy. 

d. CORDIS IP-cure-B Project Fact Sheet. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 847939.

e. The lncRNAs in HBV-Related HCCs: Targeting Chromatin Dynamics and Beyond. Vincenzo Alfano, Mirjam B. Zeisel, Massimo Levrero and Francesca Guerrieri.Cancers, 2021.

f. HBV 2021: New therapeutic strategies against an old foe. Armando Andres Roca Suarez, Barbara Testoni, and Fabien Zoulim. Liver International, 2021.